The application of systems biology to drug discovery

Current Opinion in Chemical Biology

Volumn 10, Issue 4, 2006, Pages 294-302

  Cho, Carolyn R ^a   Labow, Mark ^a   Reinhardt, Mischa ^b   van Oostrum, Jan ^b   Peitsch, Manuel C ^b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; RANOLAZINE; RAPAMYCIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ANGINA PECTORIS; BAYES THEOREM; CAENORHABDITIS ELEGANS; CANCER; CELL DIFFERENTIATION; CELL LYSATE; DATA ANALYSIS; DROSOPHILA MELANOGASTER; DRUG INDUSTRY; FLOW CYTOMETRY; FOOD AND DRUG ADMINISTRATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENOME ANALYSIS; HUNTINGTON CHOREA; MATHEMATICAL MODEL; MEDICAL LIABILITY; MYOBLAST; NONHUMAN; PROTEIN DNA INTERACTION; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SIMULATION; SYSTEMS BIOLOGY; UNITED STATES;

ANIMALS; DATABASES, GENETIC; DRUG EVALUATION, PRECLINICAL; GENOMICS; MODELS, BIOLOGICAL; PROTEOMICS; SYSTEMS BIOLOGY;

EID: 33746075170     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2006.06.025     Document Type: Review

References (96)

1. Schmid E.F., and Smith D.A. Keynote review: is declining innovation in the pharmaceutical industry a myth?. Drug Discov Today 10 (2005) 1031-1039. This analysis, based on FDA data from 1945 to 2004, shows that the increasing R&D costs are not due to a decline in innovation of the pharmaceutical industry.
2. Fishman M.C., and Porter J.A. A new grammar for drug discovery. Nature 437 (2005) 491-493
3. Butcher E.C., Berg E.L., and Kunkel E.J. System biology in drug discovery. Nat Biotechnol 22 (2004) 1253-1259
4. Apic G., Ignjatovic T., Boyer S., and Russell R.B. Illuminating drug discovery with biological pathways. FEBS Lett 579 (2005) 1872-1877
5. van der Greef J., and McBurney R.N. Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nat Rev Drug Discov 4 (2005) 961-967
6. Lindon J.C., Holmes E., and Nicholson J.K. Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther 6 (2004) 265-272
7. Morris M., and Watkins S.M. Focused metabolomic profiling in the drug development process: advances from lipid profiling. Curr Opin Chem Biol 9 (2005) 407-412
8. Saghatelian A., and Cravatt B.J. Global strategies to integrate the proteome and metabolome. Curr Opin Chem Biol 9 (2005) 62-68
9. Luo M., Reyna S., Wang L., Yi Z., Carroll C., Dong L.Q., Langlais P., Weintraub S.T., and Mandarino L.J. Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223. Endocrinology 146 (2005) 4410-4416
10. Bouwmeester T., Bauch A., Ruffner H., Angrand P.O., Bergamini G., Croughton K., Cruciat C., Eberhard V., Gagneur J., Ghidelli S., et al. A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nat Cell Biol 6 (2004) 97-105
11. Schulze W.X., Deng L., and Mann M. Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Systems Biol 1 (2005) 42-54
12. Jones R.B., Gordus A., Krall J.A., and MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439 (2006) 168-174
13. Hultschig C., Kreutzberger J., Seitz H., Konthur Z., Büssow K., and Lehrach H. Recent advances of protein microarrays. Curr Opin Chem Biol 10 (2006) 4-10
14. Nielsen U.B., Cardone M.H., Sinskey A.J., MacBeath G., and Sorger P.K. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci USA 100 (2003) 9330-9335
15. Gulmann C., Sheehan K.M., Kay E.W., Liotta L.A., and Petricoin E.F. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. J Pathol 208 (2006) 595-606. The authors review forward-phase and reverse-phase protein arrays in a number of applications.
16. Balboni I., Chan S.M., Kattah M., Tenenbaum J.D., Butte A.J., and Utz P.J. Multiplexed protein array platforms for analysis of autoimmune diseases. Annu Rev Immunol 24 (2006) 391-418
17. Nishizuka S., Charboneau L., Young L., Major S., Reinhold W.C., Waltham M., Kouros-Mehr H., Bussey K.J., Lee J.K., Espina V., et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 100 (2003) 14229-14234
18. Wulfkuhle J.D., Aquino J.A., Calvert V.S., Fishman D.A., Coukos G., Liotta L.A., and Petricoin E.F. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3 (2003) 2085-2090
19. Sheehan K.M., et al. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 4 (2005) 346-355
20. Janzi M., Oedling J., Pan-Hammarström Q., Sundberg M., Lundeberg J., Uhlén M., Hammarström L., and Nilsson P. Serum microarrays for large scale screening of protein levels. Mol Cell Proteomics 4 (2005) 1942-1947. The authors analyzed over 2000 serum samples using reverse arrays and compared the data with clinical routine measurements. The results suggest that reverse protein arrays can be used to screen clinical serum samples.
21. Amini B., Andersen E., Andersson A.C., Angelidou P., Asplund A., Asplund C., Berglund L., Bergström K., Brumer H., Cerjan D., et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4 (2005) 1920-1932
22. Nilsson P., Paavilainen L., Larsson K., Odling J., Sundberg M., Andersson A.C., Kampf C., Persson A., Al-Khalili Szigyarto C., Ottosson J., et al. Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. Proteomics 5 (2005) 4327-4337
23. Binz H.K., Amstutz P., and Plückthun A. Engineering novel binding proteins from nonimmunoglobin domains. Nat Biotechnol 23 (2005) 1257-1268
24. Irish J.M., Kotecha N., and Nolan G.P. Mapping normal and cancer cell signaling networks: towards single-cell proteomics. Nat Rev Cancer 6 (2006) 146-155
25. Iourgenko V., Zhang W., Mickanin C., Daly I., Jiang C., Hexham J.M., Orth A.P., Miraglia L., Meltzer J., Garza D., et al. Identification of a family of cAMP response element-binding protein co-activators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci USA 100 (2003) 12147-12152
26. Bittinger M.A., McWhinnie E., Meltzer J., Iourgenko V., Latario B., Liu X., Chen C.H., Song C., Garza D., and Labow M. Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins. Curr Biol 14 (2004) 2156-2161
27. Ito M., Kawano K., Miyagishi M., and Taira K. Genome-wide application of RNAi to the discovery of potential drug targets. FEBS Lett 579 (2005) 5988-5995
28. Wheeler D.B., Carpenter A.E., and Sabatini D.M. Cell microarrays and RNA interference chip away at gene function. Nat Genet 37 Suppl (2005) S25-S30
29. Bailey S.N., Ali S.M., Carpenter A.E., Higgins C.O., and Sabatini D.M. Microarrays of lentiviruses for gene function screens in immortalized and primary cells. Nat Methods 3 (2006) 117-122
30. Paddison P.J., Silva J.M., Conklin D.S., Schlabach M., Li M., Aruleba S., Balija V., O'Shaughnessy A., Gnoj L., Scobie K., et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428 (2004) 427-431
31. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124 (2006) 1283-1298. Describes a library of 22 000 RNAi reagents that can be used in loss of function screens in human and murine systems.
32. Huesken D., Lange J., Mickanin C., Weiler J., Asselbergs F., Warner J., Meloon B., Engel S., Rosenberg A., Cohen D., et al. Design of a genome-wide siRNA library using an artificial neural network. Nat Biotechnol 23 (2005) 995-1001
33. Boutros M., Kiger A.A., Armknecht S., Kerr K., Hild M., Koch B., Haas S.A., Paro R., and Perrimon N. Heidelberg fly array consortium: genome-wide RNAi analysis of growth and viability in drosophila cells. Science 303 (2004) 832-835
34. Carpenter A.E., and Sabatini D.M. Systematic genome-wide screens of gene function. Nat Rev Genet 5 (2004) 11-22
35. Dasgupta R., and Perrimon N. Using RNAi to catch Drosophila genes in a web of interactions: insights into cancer research. Oncogene 23 (2004) 8359-8365
36. Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A., Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B., et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428 (2004) 431-437
37. Sieburth D., Ch'ng Q., Dybbs M., Tavazoie M., Kennedy S., Wang D., Dupuy D., Rual J.F., Hill D.E., Vidal M., et al. Systematic analysis of genes required for synapse structure and function. Nature 436 (2005) 510-517
38. Willingham A.T., Orth A.P., Batalov S., Peters E.C., Wen B.G., Aza-Blanc P., Hogenesch J.B., and Schultz P.G. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 309 (2005) 1570-1573
39. Bentwich I. Prediction and validation of microRNAs and their targets. FEBS Lett 579 (2005) 5904-5910
40. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37 (2005) 766-770
41. Allison D.B., Cui X.Q., Page G.P., and Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Genet 7 (2006) 55-65
42. Pe'er D., Regev A., Elidan G., and Friedman N. Inferring subnetworks from perturbed expression profiles. Bioinformatics 17 (2001) S215-S224
43. Bar-Joseph Z., Gerber G.K., Lee T.I., Rinaldi N.J., Yoo J.Y., Robert F., Gordon D.B., Fraenkel E., Jaakkola T.S., Young R.A., and Gifford D.K. Computational discovery of gene modules and regulatory networks. Nat Biotechnol 21 (2003) 1337-1342
44. Kanehisa M., Goto S., Hattori M., Aoki-Kinoshita K.F., Itoh M., Kawashima S., Katayama T., Araki M., and Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34 (2006) D354-D357
45. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34 (2003) 267-273. Describes gene set enrichment analysis and how this method detects modest but coordinated changes in the expression of groups of functionally related genes. The authors demonstrate how this method can be applied to the analysis of expression data obtained from biopsies.
46. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., and Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102 (2005) 15545-15550
47. Hodges A., Strand A.D., Aragaki A.K., Kuhn A., Sengstag T., Hughes G., Elliston L.A., Hartog C., Goldstein D.R., Thu D., et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 15 (2006) 965-977
48. Szustakowski J.D., Lee J.H., Marrese C.A., Kosinski P.A., Nimala N.R., and Kemp D.M. Identification of novel pathway regulation during myogenic differentiation. Genomics 87 (2006) 129-138
49. Bild A.H., Yao G., Chang J.T., Wang Q.L., Potti A., Chasse D., Joshi M.B., Harpole D., Lancaster J.M., Berchuck A., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439 (2006) 353-357. Demonstrates how the combination of patterns of pathway deregulations distinguishes between cancer types, reflects their biology and outcome and how they are predictive for treatment sensitivity in cell cultures.
50. Oda K., Matsuoka Y., Funahashi A., and Kitano H. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Systems Biol 1 (2005) 8-24. This review presents a high-quality literature-based network reconstruction of EGF signaling.
51. Shatkay H., Edwards S., Wilbur W.J., and Boguski M. Genes, themes and microarrays: using information retrieval for large-scale gene analysis. Proc Int Conf Intell Syst Mol Biol 8 (2000) 317-328
52. Jensen L.J., Saric J., and Bork P. Literature mining for the biologist: from information retrieval to biological discovery. Nat Rev Genet 7 (2006) 119-129. Using an example sentence, this review presents a good overview of literature mining for biologists describing the different techniques, what they can be used for and what their limitations are.
53. Rajasethupathy P., Vayttaden S.J., and Bhalla U.S. Systems modeling: a pathway to drug discovery. Curr Opin Chem Biol 9 (2005) 400-406
54. Hanisch D., Fundel K., Mevissen H.T., Zimmer R., and Fluck J. Prominer: rule-based protein and gene entity recognition. BMC Bioinformatics 6 (2005) S14
55. Cohen A.M., Hersh W.R., Dubay C., and Spackman K. Using co-occurrence network structure to extract synonymous gene and protein names from medline abstracts. BMC Bioinformatics 6 (2005) 103
56. Chen L., Liu H., and Friedman C. Gene name ambiguity of eukaryotic nomenclatures. Bioinformatics 21 (2005) 248-256
57. Gaudan S., Kirsch H., and Rebholz-Schuhmann D. Resolving abbreviations to their senses in Medline. Bioinformatics 21 (2005) 3658-3664
58. Schijvenaars B.J., Mons B., Weeber M., Schuemie M.J., van Mulligen E.M., Wain H.M., and Kors J.A. Thesaurus-based disambiguation of gene symbols. BMC Bioinformatics 6 (2005) 149
59. Cooper J.W., and Kershenbaum A. Discovery of protein-protein interactions using a combination of linguistic, statistical and graphical information. BMC Bioinformatics 6 (2005) 143
60. Ramani A.K., Bunescu R.C., Mooney R.J., and Marcotte E.M. Consolidating the set of known human protein-protein interactions in preparation for large-scale mapping of the human interactome. Genome Biol 6 (2005) R40
61. Alako B.T., Veldhoven A., van Baal S., Jelier R., Verhoeven S., Rullmann T., Polman J., and Jenster G. Copub mapper: mining Medline based on search term co-publication. BMC Bioinformatics 6 (2005) 51
62. Temkin J.M., and Gilder M.R. Extraction of protein interaction information from unstructured text using a context-free grammar. Bioinformatics 19 (2003) 2046-2053
63. Daraselia N., Yuryev A., Egorov S., Novichkova S., Nikitin A., and Mazo I. Extracting human protein interactions from Medline using a full-sentence parser. Bioinformatics 20 (2004) 604-611
64. Rzhetsky A., Iossifov I., Koike T., Krauthammer M., Kra P., Morris M., Yu H., Duboue P.A., Weng W., Wilbur W.J., et al. Geneways: a system for extracting, analyzing, visualizing, and integrating molecular pathway data. J Biomed Inform 37 (2004) 43-53
65. Narayanaswamy M., Ravikumar K.E., and Vijay-Shanker K. Beyond the clause: extraction of phosphorylation information from Medline abstracts. Bioinformatics 21 (2005) i319-i327
66. Saric J., Jensen L.J., Ouzounova R., Rojas I., and Bork P. Extraction of regulatory gene/protein networks from Medline. Bioinformatics 22 (2005) 645-650
67. Chen H., and Sharp B.M. Content-rich biological network constructed by mining Pubmed abstracts. BMC Bioinformatics 5 (2004) 147
68. Krauthammer M., Kaufmann C.A., Gilliam T.C., and Rzhetsky A. Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease. Proc Natl Acad Sci USA 101 (2004) 15148-15153. The authors integrated literature-based molecular networks and genetic linkage maps to find candidate disease genes.
69. Tiffin N., Kelso J.F., Powell A.R., Pan H., Bajic V.B., and Hide W.A. Integration of text- and data-mining using ontologies successfully selects disease gene candidates. Nucleic Acids Res 33 (2005) 1544-1552. The authors combined tissue-expression data with disease-tissue relationships extracted from the literature to predict candidate disease genes.
70. Hu Y., Hines L.M., Weng H., Zuo D., Rivera M., Richardson A., and LaBaer J. Analysis of genomic and proteomic data using advanced literature mining. J Proteome Res 2 (2003) 405-412
71. Korbel J.O., Doerks T., Jensen L.J., Perez-Iratxeta C., Kaczanowski S., Hooper S.D., Andrade M.A., and Bork P. Systematic association of genes to phenotypes by genome and literature mining. PLoS Biol 3 (2005) e134. The authors combined comparative prokaryote genome analysis with literature mining and uncovered genes that might play a role in infectious diseases.
72. Grandjean N., Charpiot B., Pena C.A., and Peitsch M.C. Competitive intelligence and patent analysis in drug discovery. Mining the competitive knowledge bases and patents. Drug Discov Today: Technol 3 (2005) 211-215
73. Natarajan J, Berrar D, Dubitzky W, Hack CJ, Zhang Y, DeSesa C, Van Brocklyn JR, Bremer EG: Text mining of full-text journal articles combined with gene expression analysis reveals a relationship between sphingosine-1-phosphate and invasivity of a glioblastoma cell line. BMC Bioinformatics 2006, in press.
74. Natarajan J., Mulay N., DeSesa C., Hack C.J., Dubitzky W., and Bremer E.G. A grid infrastructure for text mining of full text articles and creation of a knowledge base of gene relations. Lecture Notes in Bioinformatics 3745 (2005) 101-108
75. Natarajan J., Haines C., Berglund B., DeSesa C., Hack C.J., Dubitzky W., and Bremer E.G. Getitfull - a tool for downloading and pre-processing full-text journal articles. Lecture Notes in Computer Science 3869 (2006) 139-145
76. Romacker M, Grandjean N: 002C Parisot P, Kreim O, Cronenberger D, Vachon T, Peitsch MC: The Ultralink: an expert system for contextual hyperlinking in knowledge management. In Computer Applications in Pharmaceutical Research and Development. Edited by Ekins S. Wiley & Sons; 2006:729-753.
77. Janes K.A., and Lauffenburger D.A. A biological approach to computational models of proteomic networks. Curr Opin Chem Biol 10 (2006) 73-80
78. Kholodenko B.N. Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 7 (2006) 165-176. Detailed review of principles, archetypical dynamical behaviors (feedback, bistable switch and oscillators), and some classical examples.
79. Eungdamrong N.J., and Iyengar R. Computational approaches for modeling regulatory cellular networks. Trends Cell Biol 14 (2004) 661-669. This article uses a MAPK example to orient the reader through a review of methods, including a review of open access tools available at the time. For an updated list see http://www.sbml.org.
80. Arnold S., Siemann-Herzberg M., Schmid J., and Reuss M. Model-based inference of gene expression dynamics from sequence information. Adv Biochem Eng Biotechnol 100 (2005) 89-179. Extended review for the expert who wishes to follow the model from building and validation through detailed analysis.
81. Le Novere N., Finney A., Hucka M., Bhalla U.S., Campagne F., Collado-Vides J., Crampin E.J., Halstead M., Klipp E., Mendes P., et al. Minimum information requested in the annotation of biochemical models (MIRIAM). Nat Biotechnol 23 (2005) 1509-1515
82. Karp P.D., and Mavrovouniotis M.L. Representing, analyzing, and synthesizing biochemical pathways. IEEE Expert 9 (1994) 11-21
83. Kitano H., Funahashi A., Matsuoka Y., and Oda K. Using process diagrams for the graphical representation of biological networks. Nat Biotechnol 23 (2005) 961-966
84. Chien J.Y., Friedrich S., Heathman M.A., de Alwis D.P., and Sinha V. Pharmacokinetics/pharmacodynamics and the stages of drug development: role of modeling and simulation. AAPS J 7 (2005) E544-E559
85. Andersen M.E., Thomas R.S., Gaido K.W., and Conolly R.B. Dose-response modeling in reproductive toxicology in the systems biology era. Reprod Toxicol 19 (2005) 327-337
86. Blinov M.L., Faeder J.R., Goldstein B., and Hlavacek W.S. Bionetgen: software for rule-based modeling of signal transduction based on the interactions of molecular domains. Bioinformatics 20 (2004) 3289-3291
87. Lin X., Floudas C.A., Wang Y., and Broach J.R. Theoretical and computational studies of the glucose signaling pathways in yeast using global gene expression data. Biotechnol Bioeng 84 (2003) 864-886
88. Araujo R.P., and Liotta L.A. A control theoretic paradigm for cell signaling networks: a simple complexity for a sensitive robustness. Curr Opin Chem Biol 10 (2006) 81-87
89. Ma'ayan A., Blitzer R.D., and Iyengar R. Toward predictive models of mammalian cells. Annu Rev Biophys Biomol Struct 34 (2005) 319-349
90. Fisher J., Piterman N., Hubbard E.J., Stern M.J., and Harel D. Computational insights into Caenorhabditis elegans vulval development. Proc Natl Acad Sci USA 102 (2005) 1951-1956
91. Errampalli D.D., Priami C., and Quaglia P. A formal language for computational systems biology. OMICS 8 (2004) 370-380
92. Fages F., Soliman S., and Chabrier-Rivier N. Modelling and querying interaction networks in the biochemical abstract machine BIOCHAM. J Bio Phys Chem 4 (2004) 64-73
93. Mendoza L., and Xenarios I. A method for the generation of standardized qualitative dynamical systems of regulatory networks. Theor Biol Med Model 3 (2006) 13
94. Rice J.J., and Stolovitzky G. Making the most of it: pathway reconstruction and integrative simulation using the data at hand. Biosilico 2 (2004) 70-77
95. Bottino D., Penland R.C., Stamps A., Traebert M., Dumotier B., Georgiva A., and Helmlinger G. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart. Prog Biophys Mol Biol 90 (2006) 414-443
96. Fredj S., Sampson K.J., Liu H., and Kass R.S. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action. Br J Pharmacol 148 (2006) 16-24